Kuiken schreef op 29 maart 2022 19:03:
Dit kwam uit in twee posts hierboven gemelde conferentie, bron Alzheimer Today. ( ik kan dit niet toetsen aan Vivo"s bezigheden, daar is het mij te specialistisch voor)
Dual Vaccine Shows Promise for Treating Alzheimer’s in Early Study
by Margarida Maia PhD | March 28, 2022
A dual vaccine targeting both amyloid plaques and tangled fibers made up of tau — two abnormal protein aggregates that build up in the brain of those with Alzheimer’s — may have potential to treat and prevent the disease.
Prothena, its developer, has found preclinical evidence that the vaccine drives the generation of a sufficient amount of antibodies that are able to bind to and neutralize both amyloid and tau proteins, with reasonable safety.
These characteristics are hard to find and have previously prevented the development of safe and effective vaccines for Alzheimer’s.
“The need for vaccines to prevent Alzheimer’s … from ever occurring is urgent,” Wagner M. Zago, PhD, chief scientific officer of Prothena, said in a press release.